We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.
我們正在追蹤 Ipsen 的市場擴張
過去 90 日內有 32 個訊號。
Ipsen 的國際擴張與競爭對手的比較
Ipsen你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Ipsen你 | 0 | 0 | — | 0 | 0 |
Microbiologist – Ipsen Wrexham
查看招聘Wrexham, Wales, United Kingdom · 2星期前
National Corporate Accounts Director
查看招聘New York, NY · 上星期
Vice President, Head of External Innovation China, Strategy & Operations
查看招聘Cambridge, MA · 上星期
Glasses on. Meetings moved outside. Coffee on the terrasse. This is what spring at Ipsen HQ looks like. ☀️Same mission. Much better backdrop. ...
已結束Paris 🇫🇷 London 🇬🇧 Cambridge 🇺🇸Different views outside the windows, but the same spirit inside: we share ideas, move fast, and focus on what matters most—people and patients.Same mission. Just a few time zones apart. ...
已結束
Download the 2025 Integrated Annual Report
已結束益普生報告2025年第一季度銷售額以固定匯率計算增長11.6%，由三個治療領域推動。公司確認2025年全年財務指引並強調研發管線進展。
Ipsen報告Onivyde在胰腺癌治療中的三期試驗取得積極結果，顯示轉移性胰腺腺癌長期存活患者的中位總生存期為19.5個月。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Ipsen 業務、市場及增長訊號的快速解答。
